1. DEVEC: A PHASE II STUDY OF METRONOMIC CHEMOTHERAPY IN ELDERLY NON‐FIT PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMAS (PROMOTED BY FIL). (June 2017) Authors: Cox, M.C.; Musuraca, G.; Arcari, A.; Fabbri, A.; Gini, G.; Tani, M.; Tucci, A.; Marcheselli, L.; Storti, S.; Di Landro, F.; Battistini, R.; Anticoli Borza, P.; Casaroli, I.; Zoli, V.; Fabbri, F.; Aroldi, A.; Naso, V.; Bianchi, M.; Borgo, E.; Ferranti, A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LENALIDOMIDE AND RITUXIMAB (ReRi) AS FRONT LINE THERAPY OF ELDERLY FRAIL PATIENTS WITH DIFFUSE LARGE B‐CELLS LYMPHOMA. FIRST PLANNED INTERIM ANALYSIS OF A PHASE II STUDY OF THE FONDAZIONE ITALIANA LINFOMI (FIL). (12th June 2019) Authors: Gini, G.; Tani, M.; Bassan, R.; Tucci, A.; Ballerini, F.; Sampaolo, M.; Merli, F.; Re, F.; Annibali, O.; Liberati, A.; Visco, C.; Arcari, A.; Storti, S.; Fabbri, A.; Musuraca, G.; Zilioli, V.; Cox, M.; Luminari, S. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗